DelveInsight’s, “Schizophrenia Pipeline Insight” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Schizophrenia pipeline landscape. It covers the Schizophrenia ...
A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has ...
The proportion of new cases of schizophrenia associated with a cannabis use disorder has risen from 4% pre-legalization to 10 ...
A study in Ontario found that schizophrenia cases linked to cannabis use disorder have more than doubled since cannabis ...
The family of a vulnerable man who drowned after wading into the sea has received “unreserved apologies” for failings by ...